At May 2, 2012 RepliCel Life Sciences Inc was pleased to report positive results from its interim analysis of six-month post-injection data collected from its first-in-man clinical trial (TS001-2009) designed to test the safety and efficacy of the RepliCel™ technology in men and women with androgenetic alopecia (pattern baldness). The primary protocol objective of the [...]
Positive results but not overwhelming from RepliCel first clinical trial
May 2, 2012 By Leave a Comment
Scientist Discover Protein Responsible for MPB
March 19, 2012 By 2 Comments
Researchers have identified the protein responsible for male pattern baldness, raising expectations that an effective treatment for the most common cause of hair loss in men is on the horizon. Male pattern baldness affects 8 out of 10 men and causes the hair follicles to shrink and produce microscopic hairs, which grow for a shorter [...]